43 results on '"Tagat, Jayaram R."'
Search Results
2. SCH 1473759, a novel Aurora inhibitor, demonstrates enhanced anti-tumor activity in combination with taxanes and KSP inhibitors
3. Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection
4. Interaction of small molecule inhibitors of HIV-1 entry with CCR5
5. Synthesis of mono- and difluoronaphthoic acids
6. Inhibition of the Development of Collagen-Induced Arthritis in Rhesus Monkeys by a Small Molecular Weight Antagonist of CCR5
7. Discovery of a highly potent orally bioavailable imidazo-[1, 2-a]pyrazine Aurora inhibitor
8. Discovery of a highly potent orally bioavailable imidazo-[1, 2- a ]pyrazine Aurora inhibitor
9. Aurora Kinase Inhibitors Based on the Imidazo[1,2-a]pyrazine Core: Fluorine and Deuterium Incorporation Improve Oral Absorption and Exposure
10. CCR 5 Antagonists: Small‐Molecule Inhibitors For Blocking HIV ‐1 Entry
11. Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-a]-Pyrazine Core
12. ChemInform Abstract: A Novel Method for the Synthesis of Aryl Sulfones.
13. ChemInform Abstract: Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. Part 1. 2(S)-Methyl Piperazine as a Key Pharmacophore Element.
14. ChemInform Abstract: Synthesis of Mono- and Difluoronaphthoic Acids.
15. Himbacine derived thrombin receptor antagonists: Discovery of a new tricyclic core
16. Discovery and Development of Small-Molecule Chemokine Coreceptor CCR5 Antagonists
17. Discovery and Characterization of Vicriviroc (SCH 417690), a CCR5 Antagonist with Potent Activity against Human Immunodeficiency Virus Type 1
18. Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. IV. Discovery of 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-{2-methoxy-1(R)-4-(trifluoromethyl)phenyl}ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a Potent, Highly Selective, and Orally Bioavailable CCR5 Antagonist
19. Piperazine‐Based CCR5 Antagonists as HIV‐1 Inhibitors. Part 3. Synthesis, Antiviral and Pharmacokinetic Profiles of Symmetrical Heteroaryl Carboxamides (VIII).
20. Analysis of the Mechanism by Which the Small-Molecule CCR5 Antagonists SCH-351125 and SCH-350581 Inhibit Human Immunodeficiency Virus Type 1 Entry
21. Piperazine-based CCR5 antagonists as HIV-1 inhibitors. III: synthesis, antiviral and pharmacokinetic profiles of symmetrical heteroaryl carboxamides
22. Substituted 2-(R)-Methyl piperazines as muscarinic M2 selective ligands
23. Synthesis and structure–Activity relationships of M2-Selective muscarinic receptor ligands in the 1-[4-(4-Arylsulfonyl)-phenylmethyl]-4-(4-piperidinyl)-piperazine family
24. Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. II. Discovery of 1-[(2,4-Dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoro- methyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-Oxide (Sch-350634), an Orally Bioavailable, Potent CCR5 Antagonist
25. Metabolic stabilization of benzylidene ketal M2 muscarinic receptor antagonists via halonaphthoic acid substitution
26. Piperazine-Based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element
27. A novel method for the synthesis of aryl sulfones
28. A scalemic synthesis of the scopadulcic acid skeleton. II: Ring-D formation via regiospecific intramolecular aldol and alkylation reactions
29. A scalemic synthesis of the scopadulcic acid skeleton. I: An efficient γ-alkylation at C-9 in abietane framework and subsequent aldol reaction
30. Synthetic inhibitors of interleukin-6 I: 2,3,7,8-tetrahydro-4-aryl-1H-cyclopent [e] imidazo [1,2-a]- pyridin-5(6H)-one and related compounds
31. Synthetic inhibitors of interleukin-6 II: 3,5-diaryl pyridines and meta-terphenyls
32. Synthesis and anti-herpes activity of some a-ring functionalized dehydroabietane derivatives
33. Synthesis and chemistry of thia-analogs of the anti-mitotic podophyllium lignans
34. Synthesis and structure–Activity relationships of M 2-Selective muscarinic receptor ligands in the 1-[4-(4-Arylsulfonyl)-phenylmethyl]-4-(4-piperidinyl)-piperazine family
35. Substituted 2-( R)-Methyl piperazines as muscarinic M 2 selective ligands
36. Piperazine-Based CCR5 antagonists as HIV-1 inhibitors. I: 2( S)-methyl piperazine as a key pharmacophore element
37. Metabolic stabilization of benzylidene ketal M 2 muscarinic receptor antagonists via halonaphthoic acid substitution
38. ChemInform Abstract: Synthesis of Mono- and Difluoronaphthoic Acids.
39. ChemInform Abstract: Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. Part 1. 2(S)-Methyl Piperazine as a Key Pharmacophore Element.
40. ChemInform Abstract: A Novel Method for the Synthesis of Aryl Sulfones.
41. Preface [Hot Topic: Recent Advances in the Treatment of HIV Infection (Guest Editor: Jayaram R. Tagat)]
42. Aurora kinase inhibitors based on the imidazo[1,2-a]pyrazine core: fluorine and deuterium incorporation improve oral absorption and exposure.
43. Discovery and development of small-molecule chemokine coreceptor CCR5 antagonists.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.